ArticleCells2023

RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect.

Jian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.